(Q44826148)

6 December 2017

title

Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy (English)

1 reference

6 December 2017

Daliu Min

1

1 reference

6 December 2017

Feng Lin

2

1 reference

6 December 2017

Zan Shen

3

1 reference

6 December 2017

Shuier Zheng

4

1 reference

6 December 2017

Lina Tan

5

1 reference

6 December 2017

Wenxi Yu

6

1 reference

6 December 2017

Yang Yao

7

1 reference

6 December 2017

publication date

23 July 2012

1 reference

Asia Pacific Journal of Clinical Oncology

6 December 2017

published in

1 reference

6 December 2017

volume

9

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

71-79

1 reference

Common musculoskeletal tumors of childhood and adolescence

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Biology and therapeutic advances for pediatric osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Current treatment of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Expression profiles of osteosarcoma that can predict response to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01560.X

10.1111/J.1743-7563.2012.01560.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference